MDxHealth SA (MDXH) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

To ask a question, you may press star, then one on your telephone keypad. To withdraw your question, please press star, then two. Please note, this event has been recorded. I would now like to turn the conference over to Mr. John Fernandez with LifeSite Advisors. Please go ahead. Good afternoon, and thank you for joining us for the MDX Health First Quarter 2025 Earnings Conference Call. Joining me on today's call are Michael McGarrity, Chief Executive Officer, and Ron Kalpas, Chief Financial Officer. Before we begin, I would like to remind everyone that the company will be making forward-looking statements during today's call. Whether in prepared remarks or during the Q&A session, these forward-looking statements are subject to inherent risks and uncertainties. These risks and uncertainties are detailed in the risk factor section of the company's filings with the Securities and Exchange Commission, specifically in the company's annual report on Form 20F. I'll now turn the call over to Michael McGarrity, Chief Executive Officer. Thanks, John. And thank you all for joining us for the first quarter 2025 Earnings Conference Call for MDX Health. With me today is Ron Kalfas, Chief Financial Officer. Our Q1 results reflect continued execution across our organization, led by our commercial team. And we remain well on track to achieve our goal of 20% or greater revenue growth in 2025 and beyond. As further evidence of our commitment to this growth objective, I think it's important to note that this Q1 2025 is our 16th consecutive quarter of 20% or greater revenue growth for MDX Health. Again, we expect our results every quarter to reflect our unwavering focus on operating discipline and commercial execution. As we look at our progress, I would point to a number of defining mi...